Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Find starter accounts offering high interest and learn how to compare introductory yields and account features quickly.
25,613 articlesA biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
As privacy coins face growing regulation, StealthEX expands its non-custodial swapping service to help traders swap m...
Growth-focused SPYG has outpaced SPYV over the last decade, a trend supported by AI spending and mega-cap tech. The g...
A renewed focus on energy equities is lifting parts of the market today. This piece breaks down what’s driving the mo...
Amundi, Europe's biggest asset manager, launches a UCITS-compliant Solana fund in partnership with SPiko Finance, mar...
Century DeAnna Realty capped a five-year growth sprint with a 110% rise in transactions, leveraging culture-driven M&...
Ford’s stock closed at its highest level in three years, powered by AI tie-ups, improving European margins, and robus...
Analysts say XRP would require a rare confluence of market, regulatory, and macro factors to hit $200 per token. Here...
Ooma stock is catching the eye of traders and long-term investors alike. Here's a clear look at the drivers, the numb...
Microsoft stock is drawing fresh attention as investors weigh AI demand against execution risk. With a trailing P/E n...
Hewlett Packard Enterprise faces a pivotal Q2 print after the market closes, with an AI backlog fueling optimism and ...
Investors weigh geopolitical risk as oil prices rise and trading desks debate the feasibility of reopening Hormuz, wi...